Core Insights - The company is focusing on systematic departmental expansion within existing customer hospitals, starting with one ICU and expanding into multiple units over time [2] - Management expects to close more accounts in 2026 than in 2025 due to an expanded salesforce and improved account acquisition processes [3][4] - The company has set a top-line growth guidance range of 25% to 29% for 2026, with potential accelerators to drive results towards the higher end of this range [5] Departmental Expansion - The company is implementing a structured approach to expand its presence in hospitals, tracking departmental expansion as a pipeline process similar to new account acquisition [2] - Currently, the company is in about 11% of U.S. hospitals and has a penetration rate of roughly 30% within those accounts [4] Pediatric and Neonatal Opportunities - The expansion into pediatric and neonatal monitoring is expected to increase the company's total addressable market by approximately $400 million, representing a 20% increase compared to the adult market [7] - There are about 800 neonatal intensive care units (NICUs) in the U.S., with roughly 200 already within existing customer accounts, presenting a near-term opportunity [8] VA System Engagement - The company has obtained FedRAMP High clearance, allowing access to the Veterans Affairs (VA) system, with a significant cohort of VA accounts committed under the 2025 budget [11] - The company is working on launching these accounts, with most expected to go live in the first half of the year [11] Gross Margin and Supply Chain - The company's gross margin was approximately 88% through 2025, projected to remain in the mid-80% range for 2026 [12] - Manufacturing efficiency improvements and cost reductions have been implemented, which also lower the tariff base and create compounding benefits [16]

Core Insights - AerSale Corporation (ASLE) reported a 17.1% increase in adjusted EBITDA for Q4 2025, rising by $2.2 million to reach $15.2 million compared to $13 million in Q4 2024 [2] - The company's revenue for Q4 2025 was $90.9 million, reflecting a 4% decrease from the previous year [2] Financial Performance - Adjusted EBITDA increased by $2.2 million, or 17.1%, to $15.2 million in Q4 2025 [2] - Revenue for Q4 2025 was reported at $90.9 million, which is a 4% decline compared to Q4 2024 [2]